Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are under 40 years of age
- People who have received a confirmed tissue biopsy diagnosis of either: (a) early-stage (Grade 1) uterine cancer affecting less than one-third of the uterine lining, or (b) atypical endometrial hyperplasia (an abnormal but non-cancerous thickening of the uterine lining)
- People whose MRI scan shows that any uterine cancer has not grown more than one-third of the way into the uterine wall muscle
- People who do not have serious health conditions that would make surgery unsafe, such as severe heart or lung conditions
- People who wish to preserve their ability to have children in the future
- People assessed by a fertility specialist as having a reasonable chance of becoming pregnant
- People who have already tried hormone therapy (specifically, medroxyprogesterone acetate at 200mg/day or megestrol acetate at 160mg/day) for at least 6 months before entering the trial
- People for whom hormone therapy either did not fully clear the abnormal cells, or who were unable to tolerate the side effects of that therapy
- People who have provided signed consent to participate in the trial
Who may not be able to join:
- People who are 40 years of age or older
- People whose uterine cancer is Grade 2 or Grade 3, or is a type other than endometrioid
- People with Grade 1 uterine cancer where more than one-third of the uterine lining is affected
- People who are not able to give informed consent to participate
- People who do not have a confirmed tissue biopsy diagnosis of the required condition
- People whose MRI scan shows the cancer has grown more than one-third of the way into the uterine wall muscle
- People whose MRI scan shows involvement of the ovaries or surrounding structures
- People who have another cancer or serious medical condition that could affect how well the trial results can be assessed
- People with significant underlying fertility problems that could interfere with the success of the surgical procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark Carey, MD, Vancouver Coastal Health
Phone: 604-875-5508
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Conception rate of women attempting pregnancy; Overall conception rate; Local disease control rate (short-term failure of hysteroscopic resection); Distant disease control rate (long-term failure of hysteroscopic resection)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.